Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 19.80
-0.20 (-1.00%)
At close: Dec 1, 2025
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 878.02 million as of December 2, 2025. Its market cap has decreased by -18.18% in one year.
Market Cap
878.02M
Enterprise Value
897.35M
Revenue
455.25M
Ranking
n/a
PE Ratio
11.25
Stock Price
19.80
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 878.02M, an increase of 172.39%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 878.02M | -16.46% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | 773.81M | 67.79% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.59B |
| Nordhealth AS | 2.88B |
| Photocure ASA | 1.68B |
| Thor Medical ASA | 1.58B |
| ArcticZymes Technologies ASA | 1.15B |
| Omda AS | 955.66M |
| Gentian Diagnostics ASA | 829.72M |
| Nykode Therapeutics AS | 702.73M |